glp 1 drugs fda approved Comparing Ozempic, Wegovy and Other GLP-1 Compounded GLP-1 Drugs and its
Description
2016;310(9):E77481
A study published in JAMA found that individuals using GLP-1 receptor agonists had a higher incidence of gallbladder-related problems compared to those on placebo
But they have not been compared in head-to-head trials
Broader use also increased the number of people potentially exposed to delayed gastric emptying, severe gastrointestinal symptoms, and other reported complications
PMC article on GLP-1 receptor agonists and alcohol-related outcomes (research context
